Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema

This study has been completed.
Genentech, Inc.
Information provided by (Responsible Party):
Retina Vitreous Associates of Florida Identifier:
First received: November 13, 2011
Last updated: October 3, 2016
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2016
  Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)